Changes to UK BCG vaccination schedules with implications for women on biologic medications during pregnancy
Abstract
Bacillus Calmette-Guerin (BCG) vaccine is a live attenuated vaccine. With declining incidence of Tuberculosis in Europe, the only countries that routinely administer BCG to all babies at birth are Ireland, Bosnia–Herzegovina, Portugal and Norway.
In the UK, BCG is given to selected groups and there has been a recent change nationally in the timing of BCG vaccination. The timing of BCG has been moved from birth to 4 weeks to facilitate a pilot into severe combined immunodeficiency screening in six areas of the UK (Manchester, Birmingham, Sheffield, Newcastle, London Great Ormond Street Hospital and London Southeast Thames).
Author
Citations
Altmetric:
Date
2022-06-29
Type
Correspondence
Subject
Gastroenterology, Obstetrics. Midwifery, Paediatrics, Public health. Health statistics. Occupational health. Health education
Collections
Citation
Parsons M, Cooney R. Changes to UK BCG vaccination schedules with implications for women on biologic medications during pregnancy. Frontline Gastroenterol. 2022 Jun 29;14(2):175-176. doi: 10.1136/flgastro-2022-102240.
Journal / Source Title
Frontline Gastroenterology
DOI
10.1136/flgastro-2022-102240
PMID
36818785
Publisher
BMJ Publishing Group
Publisher’s URL
https://fg.bmj.com/